Literature DB >> 1270590

Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers.

D D Richman, B R Murphy, S Baron, C Uhlendorf.   

Abstract

Three antigenic variants of the H3N2 subtype of wild-type influenza A virus (representing the years 1968, 1972, and 1974) were examined for their sensitivity to interferon and for their ability to induce local respiratory tract interferon in volunteers. In addition, the time of appearance of symptoms in infected volunteers was correlated with the patterns of virus shedding and interferon production. The sensitivity to interferon and the ability to stimulate nasopharyngeal interferon were similarly high for all three strains. Symptomatic illness, peak virus shedding, and peak interferon response all occurred within a 26-h period. These findings imply that interferon or its inducers theoretically could be protective if applied prophylactically, but would be less efficacious when used therapeutically.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270590      PMCID: PMC274274          DOI: 10.1128/jcm.3.3.223-226.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  MECHANISM OF RECOVERY FROM VIRAL INFECTION.

Authors:  S BARON
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

Review 2.  INTERFERON.

Authors:  A ISAACS
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

3.  Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus.

Authors:  B R Murphy; D D Richman; E G Chalhub; C P Uhlendorf; S Baron; R M Chanock
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Improved assays for a variety of interferons. 1.

Authors:  H K Oie; C E Buckler; C P Uhlendorf; D A Hill; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

5.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

6.  Sensitivity of common respiratory viruses to an interferon inducer in human cells.

Authors:  D A Hill; S Baron; R M Chanock
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

7.  Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus.

Authors:  B R Murphy; S Baron; E G Chalhub; C P Uhlendorf; R M Chanock
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

8.  Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain.

Authors:  Y Togo; R B Hornick; A T Dawkins
Journal:  JAMA       Date:  1968-03-25       Impact factor: 56.272

9.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; R M Chanock
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

10.  Adenovirus susceptibility to human interferon during one-step replication.

Authors:  J G Gallagher; N Khoobyarian
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more
  25 in total

1.  In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick; Leyi Wang; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  The impact of host immune status on the within-host and population dynamics of antigenic immune escape.

Authors:  Shishi Luo; Michael Reed; Jonathan C Mattingly; Katia Koelle
Journal:  J R Soc Interface       Date:  2012-05-09       Impact factor: 4.118

Review 3.  The relationship between encephalitis lethargica and influenza: a critical analysis.

Authors:  Sherman McCall; Joel A Vilensky; Sid Gilman; Jeffery K Taubenberger
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

4.  Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.

Authors:  Shahzma Merani; George A Kuchel; Alison Kleppinger; Janet E McElhaney
Journal:  Exp Gerontol       Date:  2017-09-27       Impact factor: 4.032

5.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

6.  Interferon response in normal and Aleutian disease virus-infected mink.

Authors:  D L Wiedbrauk; W J Hadlow; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 7.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

8.  Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains.

Authors:  Xiuyan Wang; Christopher F Basler; Bryan R G Williams; Robert H Silverman; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

Authors:  F G Hayden; A N Schlepushkin; N L Pushkarskaya
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  Towards multiscale modeling of influenza infection.

Authors:  Lisa N Murillo; Michael S Murillo; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-04-19       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.